Anne M. Noonan

Anne M. Noonan's work focuses on clinical research in gastrointestinal cancers, particularly pancreatic, liver (hepatocellular), and esophageal cancers. Her studies span clinical trials of new drug combinations (including immunotherapy, radiation-sensitizing agents, and targeted DNA-repair inhibitors), surgical and treatment outcomes, and analyses of patient care patterns and disparities using large national databases. This research is largely applied and clinical, aimed at improving treatment strategies and understanding real-world outcomes for cancer patients.

Publication output was relatively steady at 12-32 papers per year from 2017-2022, then rose sharply to a peak of 92 in 2023, followed by a gradual decline through 2025-2026, suggesting a recent burst of high activity that may be tapering off.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026